Trial Outcomes & Findings for Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology (NCT NCT05116163)

NCT ID: NCT05116163

Last Updated: 2025-11-12

Results Overview

Documented receipt of high-quality care at the appointment or within 30 days of the appointment. The quality metrics for Lupus and RA include but are not limited to: Hydroxychloroquine (HCQ) initiation and Folic acid if receiving methotrexate, respectively. These items will be added together to form a score and the number of items completed out of the total will be the primary outcome measure compared across groups. The denominator is the patient-specific quality metrics they are eligible for and the numerator is the number achieved. The final percent ranges from 0-100 (with 100 indicating that 100% of the quality metrics that the patient was eligible for were met).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

201 participants

Primary outcome timeframe

30 days

Results posted on

2025-11-12

Participant Flow

Rheumatologists were recruited from 6/17/2022-12/12/2023 at Brigham and Women's Hospital and Massachusetts General Hospital.

Rheumatologists took Implicit Association Tests and were provided with implicit bias training and then randomized to either the control or intervention arm.

Participant milestones

Participant milestones
Measure
Arm 1: Rheumatologist Individuation Intervention Plus Implicit Bias Education
Rheumatologists were randomized to this arm. They first watched implicit bias educational modules and then were instructed to incorporate an individuation strategy into each of their clinical encounters. Rheumatologists were given a choice of several individuation-related questions to better understand the unique characteristics of each patient. Once the provider decided on his/her choice phrases, the research team assisted with the development of a smart phrase (also called "dot phrase") to allow them to incorporate this into a note. Once a week, rheumatologists received an email reminding them to incorporate this question and the documentation into their encounters.
Arm 2: Rheumatologist Implicit Bias Education Only
Rheumatologists were randomized to this arm. They watched implicit bias educational modules (same as those used in Arm 1) and received no further intervention.
Patients of Arm 1 Providers- Chart Review Only
Patients of providers randomized to Arm 1 (individuation intervention). These patients were not intervened upon; their charts from routine care were reviewed only if they met inclusion criteria.
Patients of Arm 2 Providers- Chart Review Only
Patients of providers randomized to Arm 2. These patients were not intervened upon; their charts from routine care were reviewed only if they met inclusion criteria.
Patients of Arm 1 Rheumatologists Enrolled for Audiorecording
Patients of rheumatologists randomized to Arm 1 who consented for audiorecording and completed surveys, and participated in chart reviews.
Patients of Arm 2 Rheumatologists Enrolled for Audiorecording
Patients of rheumatologists randomized to Arm 2 who consented for audiorecording and completed surveys, and participated in chart reviews.
Overall Study
STARTED
10
9
81
54
20
27
Overall Study
COMPLETED
10
9
79
50
19
27
Overall Study
NOT COMPLETED
0
0
2
4
1
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1: Individuation Intervention Plus Implicit Bias Education: Rheumatologists
n=10 Participants
Rheumatologists watched implicit bias training modules and then were instructed to incorporate an individuation strategy into each of their clinical encounters.
Arm 2: Implicit Bias Education Only: Rheumatologists
n=9 Participants
Rheumatologists watched implicit bias training modules.
Patients of Arm 1- Chart Review Only
n=79 Participants
Patients of providers in Arm 1 who had their electronic health records reviewed but did not enroll/complete surveys
Patients of Arm 2- Chart Review Only
n=50 Participants
Patients of providers in Arm 2 who had their electronic health records reviewed but did not enroll/complete surveys
Patients of Arm 1 Providers With Audiorecordings and Surveys
n=20 Participants
Patients of providers in Arm 1 who enrolled for an audiorecorded encounter and surveys
Patients of Arm 2 Providers With Audiorecordings and Surveys
n=27 Participants
Patients of providers in Arm 2 who enrolled for an audiorecorded encounter and surveys
Total
n=195 Participants
Total of all reporting groups
Sex/Gender, Customized
Female
5 Participants
n=10 Participants
5 Participants
n=9 Participants
53 Participants
n=79 Participants
37 Participants
n=50 Participants
11 Participants
n=20 Participants
17 Participants
n=27 Participants
128 Participants
n=195 Participants
Sex/Gender, Customized
Male
5 Participants
n=10 Participants
4 Participants
n=9 Participants
6 Participants
n=79 Participants
4 Participants
n=50 Participants
4 Participants
n=20 Participants
2 Participants
n=27 Participants
25 Participants
n=195 Participants
Age, Categorical
<=18 years
0 Participants
n=10 Participants
0 Participants
n=9 Participants
0 Participants
n=79 Participants
0 Participants
n=50 Participants
0 Participants
n=20 Participants
0 Participants
n=27 Participants
0 Participants
n=195 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=10 Participants
8 Participants
n=9 Participants
53 Participants
n=79 Participants
38 Participants
n=50 Participants
17 Participants
n=20 Participants
23 Participants
n=27 Participants
148 Participants
n=195 Participants
Age, Categorical
>=65 years
1 Participants
n=10 Participants
1 Participants
n=9 Participants
26 Participants
n=79 Participants
12 Participants
n=50 Participants
3 Participants
n=20 Participants
4 Participants
n=27 Participants
47 Participants
n=195 Participants
Sex/Gender, Customized
Unknown
0 Participants
n=10 Participants
0 Participants
n=9 Participants
20 Participants
n=79 Participants
9 Participants
n=50 Participants
5 Participants
n=20 Participants
8 Participants
n=27 Participants
42 Participants
n=195 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=10 Participants
3 Participants
n=9 Participants
9 Participants
n=79 Participants
10 Participants
n=50 Participants
2 Participants
n=20 Participants
5 Participants
n=27 Participants
29 Participants
n=195 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
n=10 Participants
6 Participants
n=9 Participants
67 Participants
n=79 Participants
38 Participants
n=50 Participants
17 Participants
n=20 Participants
21 Participants
n=27 Participants
158 Participants
n=195 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=10 Participants
0 Participants
n=9 Participants
3 Participants
n=79 Participants
2 Participants
n=50 Participants
1 Participants
n=20 Participants
1 Participants
n=27 Participants
8 Participants
n=195 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=10 Participants
0 Participants
n=9 Participants
0 Participants
n=79 Participants
1 Participants
n=50 Participants
0 Participants
n=20 Participants
0 Participants
n=27 Participants
1 Participants
n=195 Participants
Race (NIH/OMB)
Asian
1 Participants
n=10 Participants
2 Participants
n=9 Participants
0 Participants
n=79 Participants
0 Participants
n=50 Participants
1 Participants
n=20 Participants
0 Participants
n=27 Participants
4 Participants
n=195 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=10 Participants
0 Participants
n=9 Participants
0 Participants
n=79 Participants
0 Participants
n=50 Participants
0 Participants
n=20 Participants
0 Participants
n=27 Participants
0 Participants
n=195 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=10 Participants
1 Participants
n=9 Participants
61 Participants
n=79 Participants
37 Participants
n=50 Participants
14 Participants
n=20 Participants
23 Participants
n=27 Participants
136 Participants
n=195 Participants
Race (NIH/OMB)
White
8 Participants
n=10 Participants
6 Participants
n=9 Participants
10 Participants
n=79 Participants
6 Participants
n=50 Participants
3 Participants
n=20 Participants
4 Participants
n=27 Participants
37 Participants
n=195 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=10 Participants
0 Participants
n=9 Participants
2 Participants
n=79 Participants
1 Participants
n=50 Participants
0 Participants
n=20 Participants
0 Participants
n=27 Participants
3 Participants
n=195 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=10 Participants
0 Participants
n=9 Participants
6 Participants
n=79 Participants
5 Participants
n=50 Participants
2 Participants
n=20 Participants
0 Participants
n=27 Participants
14 Participants
n=195 Participants
Region of Enrollment
United States
10 participants
n=10 Participants
9 participants
n=9 Participants
79 participants
n=79 Participants
50 participants
n=50 Participants
20 participants
n=20 Participants
27 participants
n=27 Participants
248 participants
n=195 Participants
Provider-Only Implicit Association Test- Race Bias
-0.46 units on a scale
STANDARD_DEVIATION 0.54 • n=10 Participants • This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
-0.37 units on a scale
STANDARD_DEVIATION 0.57 • n=9 Participants • This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
—
—
—
—
-0.42 units on a scale
STANDARD_DEVIATION 0.54 • n=19 Participants • This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
Provider-Only Implicit Association Tests - Race stereotyping
-0.13 units on a scale
STANDARD_DEVIATION 0.76 • n=10 Participants • Provider only surveys
-0.29 units on a scale
STANDARD_DEVIATION 0.37 • n=9 Participants • Provider only surveys
—
—
—
—
-0.20 units on a scale
STANDARD_DEVIATION 0.60 • n=19 Participants • Provider only surveys
Provider-Only Implicit Association Test - Socioeconomic status bias
0.75 units on a scale
STANDARD_DEVIATION 0.55 • n=10 Participants • Provider only surveys
0.54 units on a scale
STANDARD_DEVIATION 0.35 • n=9 Participants • Provider only surveys
—
—
—
—
0.65 units on a scale
STANDARD_DEVIATION 0.47 • n=19 Participants • Provider only surveys
Provider-Only Implicit Association Test - Socioeconomic status stereotyping
0.54 units on a scale
STANDARD_DEVIATION 0.60 • n=10 Participants • Provider only surveys
0.48 units on a scale
STANDARD_DEVIATION 0.49 • n=9 Participants • Provider only surveys
—
—
—
—
0.51 units on a scale
STANDARD_DEVIATION 0.54 • n=19 Participants • Provider only surveys
Baseline Medication Adherence
—
—
—
—
49.3 units on a scale
STANDARD_DEVIATION 19.6 • n=20 Participants • Enrolled patient-only measure
58.9 units on a scale
STANDARD_DEVIATION 18.8 • n=27 Participants • Enrolled patient-only measure
53.8 units on a scale
STANDARD_DEVIATION 19.5 • n=47 Participants • Enrolled patient-only measure

PRIMARY outcome

Timeframe: 30 days

Population: Patients of providers randomized to Arm 1 or Arm 2, which includes the eligible patients in the chart-review groups, and those who also participated in the audiorecordings and surveys

Documented receipt of high-quality care at the appointment or within 30 days of the appointment. The quality metrics for Lupus and RA include but are not limited to: Hydroxychloroquine (HCQ) initiation and Folic acid if receiving methotrexate, respectively. These items will be added together to form a score and the number of items completed out of the total will be the primary outcome measure compared across groups. The denominator is the patient-specific quality metrics they are eligible for and the numerator is the number achieved. The final percent ranges from 0-100 (with 100 indicating that 100% of the quality metrics that the patient was eligible for were met).

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Percent of Quality Metrics Achieved
62.14 Percent of Quality Metrics Achieved
Standard Deviation 13.46
54.31 Percent of Quality Metrics Achieved
Standard Deviation 14.46

SECONDARY outcome

Timeframe: At time of appointment (baseline) during which audiorecording took place, reflecting the experience at the appointment immediately preceding survey completion.

Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.

Differences in perception of patient centeredness comparing the intervention to non-intervention group. Higher scores indicate less patient-centered experiences. 4-point Likert scale, score range from 14-56.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=21 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Perception of Patient Centeredness
27.5 score on a scale
Standard Deviation 9
23.4 score on a scale
Standard Deviation 7

SECONDARY outcome

Timeframe: At time of appointment (baseline) during which audiorecording took place, reflecting the experience at the appointment immediately preceding survey completion.

Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.

Differences in patient satisfaction score, comparing the intervention to non-intervention group. Score range from 20-70. Higher scores indicate greater patient satisfaction.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=17 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=22 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Patient Satisfaction
50.4 score on a scale
Standard Deviation 9
51.5 score on a scale
Standard Deviation 8

SECONDARY outcome

Timeframe: A time of the appointment when audiorecording took place (baseline) asking patients to describe the degree to which each item occurs in their day-to-day life.

Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.

Reflects experiences of everyday discrimination, comparing the intervention to non-intervention group. Score range is 0-40. Higher scores indicate a greater amount of discrimination encountered.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=25 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Everyday Discrimination Scale
0.96 score on a scale
Standard Deviation 0.84
1.16 score on a scale
Standard Deviation 0.93

SECONDARY outcome

Timeframe: 3 months after the start of the intervention

Population: Subset of patients in the audiorecording/survey arms who returned completed 3 month follow up adherence surveys.

Adherence score (for rheumatology medications), comparing the 3-month adherence score to baseline for the intervention to non-intervention group at three months following the encounter date. Score range is 0-100 with zero being the lowest adherence, and 100 being the best.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=13 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=12 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Adherence
54.96 score on a scale
Standard Deviation 14.15
55.99 score on a scale
Standard Deviation 19.44

SECONDARY outcome

Timeframe: One time baseline evaluation from the transcript of the audiorecording of the encounter of the patient with their rheumatologist

Population: Patients who participated in audiorecordings and had transcripts for analysis.

Provider communication will be measured using the recorded transcripts and compared between arms. We compared the mean (SD) of provider positive emotion words expressed during a clinical encounter. Measured only for patients enrolled in the study who had their appointment audiorecorded.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=27 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Provider Communication: Positive Emotion Words
0.99 Number of words
Standard Deviation 0.50
0.66 Number of words
Standard Deviation 0.33

SECONDARY outcome

Timeframe: One time baseline evaluation after the appointment reflecting experiences at the immediately preceding appointment.

Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.

Patient trust in their providers, comparing the intervention to non-intervention group. Responses are summed (range 5-25) with higher scores indicating more trust.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=24 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Patient Trust
16.4 score on a scale
Standard Deviation 4
17.6 score on a scale
Standard Deviation 5

SECONDARY outcome

Timeframe: 6 months following the encounter of interest

Comparison of incidence rate of Emergency Department visits between patients of providers in the intervention compared to the control arms.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Incidence Rate Ratio of Emergency Departments Visits
0.398 number of ED visits
Standard Deviation 0.971
0.390 number of ED visits
Standard Deviation 0.934

SECONDARY outcome

Timeframe: 6 months following the encounter of interest

Comparison of incidence rate of outpatient visits between patients of providers in the intervention compared to the control arms.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Incidence Rate Ratio of Outpatient Visits.
7.34 Number of outpatient visits
Standard Deviation 6.22
6.05 Number of outpatient visits
Standard Deviation 5.88

SECONDARY outcome

Timeframe: 6 months after physician encounter

Comparison of incidence rate of hospitalizations between patients of providers in the intervention compared to the control arms.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Incidence Rate Ratio of Hospitalizations
0.316 number of hospitalizations
Standard Deviation 1.06
0.779 number of hospitalizations
Standard Deviation 0.354

SECONDARY outcome

Timeframe: Baseline compared to 6 months after the start of the intervention.

Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-high socioeconomic status bias and a score of -1 is pro-low socioeconomic status bias.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Implicit Association Test (IAT) Scores- Socioeconomic Status Stereotyping
0.50 units on a scale
Standard Deviation 0.37
0.15 units on a scale
Standard Deviation 0.50

SECONDARY outcome

Timeframe: Baseline compared to 6 months after the start of the intervention.

Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-White bias and a score of -1 is pro-Black bias.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Implicit Association Test (IAT) Scores- Race Implicit Bias
-0.27 units on a scale
Standard Deviation 0.47
0.12 units on a scale
Standard Deviation 0.44

SECONDARY outcome

Timeframe: Baseline compared to 6 months after the start of the intervention.

Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-White stereotyping and a score of -1 is pro-Black stereotyping.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Implicit Association Test (IAT) Scores- Race Stereotyping.
-0.25 units on a scale
Standard Deviation 0.61
-0.39 units on a scale
Standard Deviation 0.50

SECONDARY outcome

Timeframe: Baseline compared to 6 months after the start of the intervention.

. Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-high socioeconomic status bias and a score of -1 is pro-low socioeconomic status bias.

Outcome measures

Outcome measures
Measure
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
Implicit Association Test (IAT) Scores- Socioeconomic Status Bias
0.48 units on a scale
Standard Deviation 0.37
0.60 units on a scale
Standard Deviation 0.56

Adverse Events

Patients of Arm 1 Providers- Chart Review Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Patients of Arm 2 Providers- Chart Review Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 1 Patients Enrolled for Audiorecording

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2 Patients Enrolled for Audiorecording

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 1: Individuation Intervention Plus Implicit Bias Education

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2: Implicit Bias Education Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Candace Feldman

Brigham and Women's Hospital

Phone: 617-525-1035

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place